Pontos
Pontos is a family-owned private equity and real estate investment company based in Helsinki, Finland. Established in 2001, it operates in Finland, the Baltic States, and Portugal. The firm focuses on a diverse range of investments, including commercial real estate, property development projects, and real estate development companies. Additionally, Pontos invests in property technology, listed shares, fixed-income investments, and private equity funds, reflecting a broad investment strategy aimed at various sectors within the real estate and financial markets.
Hintsa Performance is a leading provider of human high performance services.They offer coaching services and digital tools to improve the life and performance of individuals, teams and entire organisations. Their mission is to guide individuals, teams and organisations to enjoy better life, and consequently better performance.
Blueprint Genetics Oy, founded in 2012 and based in Helsinki, Finland, specializes in clinical genetics testing with a focus on rare diseases. The company utilizes advanced Next-Generation Sequencing (NGS) technologies, including its proprietary OS-Seq™ method developed at Stanford University, to deliver high-quality genetic diagnostics. Targeting hospitals and research groups, Blueprint Genetics offers a range of services, including tailored sequencing projects and bioinformatics platforms designed to meet specific needs. The company aims to disrupt the genetic diagnostics market by reducing costs while enhancing quality and providing clinical insights in its results. Its product offerings currently include diagnostics for various hereditary conditions, particularly those affecting the cardiovascular system, such as cardiomyopathies, arrhythmias, and aortic diseases. Blueprint Genetics also operates an office in Los Angeles, California, and functions as a subsidiary of Quest Diagnostics Incorporated.
Blueprint Genetics Oy, founded in 2012 and based in Helsinki, Finland, specializes in clinical genetics testing with a focus on rare diseases. The company utilizes advanced Next-Generation Sequencing (NGS) technologies, including its proprietary OS-Seq™ method developed at Stanford University, to deliver high-quality genetic diagnostics. Targeting hospitals and research groups, Blueprint Genetics offers a range of services, including tailored sequencing projects and bioinformatics platforms designed to meet specific needs. The company aims to disrupt the genetic diagnostics market by reducing costs while enhancing quality and providing clinical insights in its results. Its product offerings currently include diagnostics for various hereditary conditions, particularly those affecting the cardiovascular system, such as cardiomyopathies, arrhythmias, and aortic diseases. Blueprint Genetics also operates an office in Los Angeles, California, and functions as a subsidiary of Quest Diagnostics Incorporated.
Valmet Automotive Inc., founded in 1968 and headquartered in Uusikaupunki, Finland, specializes in automotive engineering, manufacturing, and related services. The company produces a diverse range of vehicles, including conventional cars, electric vehicles, and driverless taxis, alongside convertible roof systems. Valmet Automotive is known for its work with premium car manufacturers, providing contractual vehicle manufacturing and electric vehicle battery systems. The company also supplies kinematic systems, such as active spoilers and electric loading flaps, for various applications in the automotive sector. With additional offices in Germany, Poland, and Spain, Valmet Automotive has established itself as a key player in the automotive industry, focusing on innovation and quality in both vehicle production and engineering services.